cucugno schreef op 23 maart 2017 17:53:
Good evening,
New day of decline, despite a splendid publication of the annual report 2016. Even if you are not bilingual, look at the PDF, pharming puts the means in communication. I have translated the most important passages you can find on the forum using google. We had a specific point on the pipelines, US army, China, clinical studies in progress .... And despite that the rise is not yet back. So it reinforces my idea that everyone waits after the FDA and the publication of the Q1 board expected in May.
I repeat it every day, I do not want to stuff you the skull but the medium and long term rise has not been damaged by the current decline.
A little explanation to understand my graphics:
- The short term represents a few days to a few weeks
- The medium term represents a few weeks to several months, it can be seen on the weekly chart.
- The long term represents a few months to several years can be seen on the monthly charts
- The very long term represents a few years, one sees on the annual charts with a major resistance to 0.34 (MM7) this year which will explode the prices over several years if annual close above 0.34
And another day of decline or the short term degrades again with the break of my triangle, the cloudl.
I remind you that despite the violent movements of last week and this week, the average and long-term increase is still valid, the short-term rise is set aside for a few days, time to break the technical resistances above our heads.
Watch the video of Trado for reminder:
tradosaure-trading.blogspot.fr/2017/0...On a daily, bad news tonight, we close under my triangle and under the cloud, wait tomorrow because it takes a candle confirmation in AT. I traced a possible new channel representing the closing of today and the lowest of January 26, we will see tomorrow if it holds.
The day laborer is always bearish. We now have a lot of resistance to pass to attack the 0.326 again and finally break them (the highest fence in recent months). When we break the 0.326 in closing we will go to 0.366 the highest of 2017. The resistances for Friday will be the cloud at 0.289, the tenkan 0.292, the mm7 at 0.294, the kijun at 0.303, the mm20 at 0.305, the SAR at 0.319 , The supertrend 0.316.
In weekly, everything is very bullish on the medium term except resistance MM7 at 0.305 and now the Tenkan at 0.316 it will be our next goal to close up next Friday.
We can see the strength of the rebound on the ichimoku weekly cloud hit last Wednesday at 0.277, the stock is still very bullish despite the jolts. I remind you that for the medium-term increase to be called into question we should close a Friday under the MM30 which this week is at 0.247, we see that we have margin and that it still blows the nugget.
To understand the graph and the reason for the rebound, look at the accuracy of the rebound on the green cloud at 0.277 but why? If we had closed below 0.277 the stock would have become neutral in the medium term instead of bullish or rebound through purchases mainly robots.
To summarize the short term is archi negative with the break of the triangle. Let us look at the medium and long term mediums that will make us bounce back. I remind you that the 0.326 serve as resistance and that when they are closed we will return to the highest of 2017 to 0.366 then to the monthly long-term cloud at 0.43 (to understand re-read on the forum the monthly AT) .
Here are the graphs:
www.actionnaires-pharming-group.sitew...In addition to the AT we will talk about several things (I put it every day for new ones):
- Our main shareholder, which is a hedge fund, sold 7% of our capital, which is approximately 30 million shares sold between the end of January and the 6th of February. It holds approximately 130 million shares and when it sells in packages, the rise will be held back
-a rare crossing mm7 and mm20 took place on 01 March 2017 which will lead to an increase of several months to a few years
- the annual MM7 is at 0.34 and in the event of closure above on 31/12, increase of several years
- We should have in the year an FDA News that is in discussion with Pharming for HAE and prophylaxis.
- Clinical trials for the auto-injection of ruconest will take place
- Analysts' opinions are at the top of the board, they range from 0.66 € to 1.40 €
I go back for the newcomers the annual Technical Analysis which should propel us very high for a few years. Why?
Why so much trust for Pharming? Our beautiful stock is at the doors of the annual MM7 which is at 0.34 and if on 31/12 it is above the prices will fly for several years up to 1-2-3-4-10 euros, Know and only the God of the purse knows it. Look at the graph below showing the proximity of Pharm and the MM7 to 0.34.
To summarize if we close above 0.34 mm7 year on 31/12 the action will surely already started its flight but its flight will last a few years. It is not the graphics that make the courses but the courses that make the graphics. So I'm not a diviner, I've invested in Pharming group for its fundamentals and only one news will take him to paradise, FDA, turnover explosion, new drug, US army, renal transplant, OPA ....
www.noelshack.com/2017-09-1488371561-...Finally I say that I own 500,000 shares, that I do not give advice of purchase or sale and that my AT is purely informative (sorry for this small sentence which serves to protect me against the evil spirits)
Cucugno (David)
www.actionnaires-pharming-group.sitew...